Latest filing published 11 Jun 2026 for Sight Sciences, Inc.. Read the official filing
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Staffan Encrantz, listed as board member, appears in our data through filings on Sight Sciences, Inc. shares, published by SEC (Form 4). In total, 22 filings cover trades dated from 19 July 2021 to 10 June 2026.
Market trades split into 15 purchases (€13.3M) and 1 sale (€2.0M). The amount is not disclosed for 1 filing. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 4 share grants. So far in 2026, the count stands at 1 purchase and no sales.
A typical purchase (the median) is worth €91k. Of 15 purchases, 2 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster.
The newest entry dates from 11 June 2026: an open-market purchase, in Sight Sciences, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
22 of 22 declarations